Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ITGR 
Integer Holdings Corp (ITGR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/23/2025: ITGR (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $137.38
1 Year Target Price $137.38
| 7 | Strong Buy |
| 2 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 23.8% | Avg. Invested days 76 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/23/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.82B USD | Price to earnings Ratio 46.83 | 1Y Target Price 137.38 |
Price to earnings Ratio 46.83 | 1Y Target Price 137.38 | ||
Volume (30-day avg) 10 | Beta 0.97 | 52 Weeks Range 66.50 - 146.36 | Updated Date 10/23/2025 |
52 Weeks Range 66.50 - 146.36 | Updated Date 10/23/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.33 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-23 | When - | Estimate 1.67 | Actual - |
Profitability
Profit Margin 4.61% | Operating Margin (TTM) 13.42% |
Management Effectiveness
Return on Assets (TTM) 4.6% | Return on Equity (TTM) 5.15% |
Valuation
Trailing PE 46.83 | Forward PE 16.56 | Enterprise Value 4909714284 | Price to Sales(TTM) 2.13 |
Enterprise Value 4909714284 | Price to Sales(TTM) 2.13 | ||
Enterprise Value to Revenue 2.74 | Enterprise Value to EBITDA 17.44 | Shares Outstanding 35034817 | Shares Floating 34635770 |
Shares Outstanding 35034817 | Shares Floating 34635770 | ||
Percent Insiders 1.19 | Percent Institutions 115.73 |
Upturn AI SWOT
Integer Holdings Corp
Company Overview
History and Background
Integer Holdings Corp, formerly Greatbatch Inc., was founded in 1970 by Wilson Greatbatch. Initially focused on battery technology for implantable medical devices, the company has evolved through organic growth and acquisitions to become a leading medical device outsource (MDO) manufacturer.
Core Business Areas
- Medical: Manufactures medical devices and components for cardiac rhythm management, neuromodulation, vascular, and other medical specialties. Includes batteries, leads, and delivery systems.
- Cardio & Vascular: Offers products for cardiovascular and vascular applications, including catheters, guidewires, and balloons.
- Neuromodulation: Creates components and devices used in neurological applications, such as spinal cord stimulation and deep brain stimulation.
Leadership and Structure
Payman Khales is the President and CEO. The company has a board of directors overseeing its operations and is structured into various business units aligned with its core business areas.
Top Products and Market Share
Key Offerings
- Medical Device Batteries: Power sources for implantable medical devices. Integer is a key player in this market. Competitors include EaglePicher Technologies and Electrochem.
- Catheters and Delivery Systems: Used in various cardiovascular procedures. This market is highly competitive with players like Boston Scientific, Medtronic, and Abbott.
- Leads for Cardiac Rhythm Management: Connect implantable pulse generators to the heart. Competitors include Medtronic, Abbott, and Boston Scientific.
Market Dynamics
Industry Overview
The medical device outsource (MDO) industry is growing, driven by increasing demand for medical devices, regulatory complexities, and cost pressures on original equipment manufacturers (OEMs).
Positioning
Integer is a leading MDO provider, focusing on complex manufacturing and technical expertise. Its competitive advantages include its scale, breadth of capabilities, and long-standing relationships with major medical device OEMs.
Total Addressable Market (TAM)
The medical device market is estimated to be in the hundreds of billions of dollars. Integer is positioned to capture a portion of the MDO market, estimated to be in the tens of billions.
Upturn SWOT Analysis
Strengths
- Strong market position
- Broad product portfolio
- Long-standing customer relationships
- Technical expertise
- Global manufacturing footprint
Weaknesses
- Customer concentration
- Dependence on key suppliers
- Exposure to regulatory changes
- Integration risks from acquisitions
Opportunities
- Expanding market for medical devices
- Increasing outsourcing trend
- Acquisitions of complementary businesses
- New product development
Threats
- Competition from other MDO providers
- Pricing pressures from OEMs
- Technological obsolescence
- Economic downturns
- Product liability claims
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Boston Scientific (BSX)
- TE Connectivity (TEL)
Competitive Landscape
Integer competes on its ability to provide a broad range of services, technical expertise, and global scale. It faces competition from larger medical device OEMs with internal manufacturing capabilities and other specialized MDO providers. Integer differentiates itself by focusing on complex, high-value manufacturing.
Major Acquisitions
Lake Region Medical
- Year: 2015
- Acquisition Price (USD millions): 764
- Strategic Rationale: Expanded Integer's product portfolio and customer base in the cardiovascular market.
Growth Trajectory and Initiatives
Historical Growth: Integer's growth has been driven by a combination of organic expansion and strategic acquisitions.
Future Projections: Analyst estimates for Integer's future growth are unavailable at the current time.
Recent Initiatives: Recent initiatives for Integer Holdings are unavailable at this time.
Summary
Integer Holdings Corp. is a leading medical device outsource manufacturer with a strong market position and broad product portfolio. While customer concentration poses a risk, the increasing demand for medical devices provides opportunities for growth. Integration of acquisitions and managing pricing pressures are critical for Integer to navigate effectively. Overall, Integer seems reasonably strong but should monitor competition.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Analyst Reports (where available)
Disclaimers:
This analysis is based on publicly available information and is intended for informational purposes only. It does not constitute financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Integer Holdings Corp
Exchange NYSE | Headquaters Plano, TX, United States | ||
IPO Launch date 2000-09-29 | President, CEO & Director Mr. Joseph W. Dziedzic | ||
Sector Healthcare | Industry Medical Devices | Full time employees 11000 | Website https://www.integer.net |
Full time employees 11000 | Website https://www.integer.net | ||
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. The company was founded in 1970 and is headquartered in Plano, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.